Tandem Diabetes Care Inc (TNDM)

Cash ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Cash and cash equivalents	US$ in thousands	58,868	79,611	130,751	127,762	172,517	123,786	114,966	93,681	71,181	112,375	98,578	120,791	94,613	129,481	222,479	74,485	51,175	46,060	38,157	40,445
Short-term investments	US$ in thousands	409,044	418,547	376,495	391,826	444,384	484,941	520,365	541,710	552,630	482,618	446,724	392,646	390,323	335,041	203,806	85,723	125,283	110,887	93,231	85,159
Total current liabilities	US$ in thousands	195,258	187,110	174,655	171,157	165,290	173,630	139,259	131,815	131,856	119,650	108,723	103,410	103,852	105,506	114,307	99,647	99,396	100,266	84,214	76,680
Cash ratio		2.40	2.66	2.90	3.04	3.73	3.51	4.56	4.82	4.73	4.97	5.02	4.97	4.67	4.40	3.73	1.61	1.78	1.57	1.56	1.64

December 31, 2023 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($58,868K + $409,044K) ÷ $195,258K
= 2.40

The cash ratio of Tandem Diabetes Care Inc has shown a declining trend over the past eight quarters, starting at 4.89 in Q1 2022 and decreasing to 2.48 in Q4 2023. This indicates that the company's ability to cover its short-term liabilities with its available cash and cash equivalents has weakened over time. The decreasing trend suggests that the company may be facing challenges in maintaining sufficient liquidity to meet its immediate financial obligations. It is essential for Tandem Diabetes Care Inc to closely monitor its cash position and take appropriate steps to improve it in order to ensure financial stability and meet its short-term liabilities effectively.